$447.27
4.18% today
NYSE, Apr 03, 06:45 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$429.33
+33.83 8.55% 1M
-75.83 15.01% 6M
+60.43 16.38% YTD
-69.89 14.00% 1Y
-60.01 12.26% 3Y
+217.94 103.10% 5Y
+275.38 178.88% 10Y
NYSE, Closing price Wed, Apr 02 2025
-3.35 0.77%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $97.61b
Enterprise Value $121.48b
P/E (TTM) P/E ratio 16.76
EV/FCF (TTM) EV/FCF 26.69
EV/Sales (TTM) EV/Sales 0.69
P/S ratio (TTM) P/S ratio 0.55
P/B ratio (TTM) P/B ratio 2.36
Dividend yield 1.52%
Last dividend (FY24) $6.52
Revenue growth (TTM) Revenue growth 3.19%
Revenue (TTM) Revenue $176.81b
EBIT (operating result TTM) EBIT $8.89b
Free Cash Flow (TTM) Free Cash Flow $4.55b
EPS (TTM) EPS $25.61
P/E forward 13.40
P/S forward 0.51
EV/Sales forward 0.63
Short interest 1.11%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

18x Buy
75%
5x Hold
21%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

Buy
75%
Hold
21%
Sell
4%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
176,810 176,810
3% 3%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 38,962 38,962
7% 7%
22%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1,393 1,393
20% 20%
1%
EBIT (Operating Income) EBIT 8,888 8,888
2% 2%
5%
Net Profit 5,980 5,980
0% 0%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Business Wire
3 days ago
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-9...
Positive
MarketBeat
3 days ago
In the world of upstart pharmaceuticals and healthcare companies, timing is everything. These firms often struggle for an extended period of time before becoming profitable, but when they see success with a new product—or even clinical trial results suggesting a new product could be on the horizon—they can experience huge rallies in a very short period of time.
Positive
Seeking Alpha
21 days ago
Elevance Health remains a buy with its strong fundamentals. An added bonus is its defensive nature during the tariff wars. Regulatory changes under Trump's administration and AI integration are key factors influencing ELV's future growth and efficiency improvements.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today